Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe +7 more·2015·Nature Communications

DOI 10.1038/ncomms7744

Cited by (1,000)

Items 301–400 of 1,000

Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy
Rille Pihlak, Jamie M. J. Weaver, Juan W. Valle, Mairead Geraldine McNamara · 2018 · Cancers
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling
Emily S. Humphrey, Shih‐Ping Su, Adnan M. Nagrial, Falko Hochgräfe, Marina Pajic, Gillian M. Lehrbach, Robert G. Parton, Alpha S. Yap, Lisa Glen Horvath, David Kuang-Fu Chang et al. · 2016 · Molecular & Cellular Proteomics
Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression
Kohei Fujikura, Masayuki Akita, Shiho Abe‐Suzuki, Tomoo Itoh, Yoh Zen · 2017 · Histopathology
Pan‐cancer RNA‐seq data stratifies tumours by some hallmarks of cancer
F. Graeme Frost, Praveen F. Cherukuri, Samuel J. Milanovich, Cornelius F. Boerkoel · 2019 · Journal of Cellular and Molecular Medicine
Analysis pipelines for cancer genome sequencing in mice
Sebastian Lange, Thomas Engleitner, Sebastian Mueller, Roman Maresch, Maximilian Zwiebel, Laura González-Silva, Günter Schneider, Ruby Banerjee, Fengtang Yang, George S. Vassiliou et al. · 2020 · Nature Protocols
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
Frank, Katrin J., Mulero-Sánchez, Antonio, Berninger, Alexandra, Ruiz-Cañas, Laura, Bosma, Astrid, Görgülü, Kıvanç, Wu, Nan, Diakopoulos, Kalliope N., Kaya-Aksoy, Ezgi, Ruess, Dietrich A. et al. · 2022 · Cell Reports Medicine
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
Corina E. Antal, Tae Gyu Oh, Stefan Aigner, En‐Ching Luo, Brian A. Yee, Tania Campos, Hervé Tiriac, Katherine L. Rothamel, Cheng Zhang, Henry Jiao et al. · 2023 · Nature Communications
Chemotherapy impacts on the cellular response to CDK4/6 inhibition: distinct mechanisms of interaction and efficacy in models of pancreatic cancer
Vishnu Muthuraj Kumarasamy, Amanda Ruiz, Ram Nambiar, Agnieszka Katarzyna Witkiewicz, Erik S. Knudsen · 2019 · Oncogene
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study
Pedro Luiz Serrano Usón, Niloy Jewel Samadder, Douglas L. Riegert‐Johnson, Lisa Boardman, Mitesh J. Borad, Daniel H. Ahn, Mohamad Bassam Sonbol, Douglas O. Faigel, Norio Fukami, Rahul Pannala et al. · 2021 · Clinical and Translational Gastroenterology
Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
Anthony Turpin, Cindy Neuzillet, Elise Colle, Nelson Dusetti, Rémy Nicolle, Jerome F. Cros, Louis de Mestier, Jean‐Baptiste Bachet, Pascal R. Hammel · 2022 · Therapeutic Advances in Medical Oncology
Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials
Mingjie Jiang, Juanjuan Dai, Dian-na Gu, Qian Huang, Ling Tian · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
An RRM–ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion
Katherine M. Collins, Yaroslav A. Kainov, Evangelos Christodoulou, Debashish Ray, Quaid Morris, Timothy R. Hughes, Ian A. Taylor, Eugene V. Makeyev, Andres Ramos · 2017 · Nucleic Acids Research
BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice
Stephanie Perkail, Jaclyn Andricovich, Kai Yan, Alexandros Tzatsos · 2020 · Nature Communications
Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity inKRASwild-type tumors
William Berry, Elizabeth M. Algar, Beena Kumar, Christopher Desmond, Michael P. Swan, Brendan John Jenkins, Daniel Gerald Croagh · 2017 · International Journal of Cancer
Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
Ou Li, Li Li, Yunru Sheng, Kun Ke, Jianzhang Wu, Yiping Mou, Mingyang Liu, Weiwei Jin · 2023 · Cancer Letters
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4
Michele Masetti, Giorgia Acquaviva, Michela Visani, Giovanni Tallini, Adele Fornelli, Moira Ragazzi, Francesco Vasuri, Daniela Grifoni, Simone Di Giacomo, Sirio Fiorino et al. · 2017 · Cancer Biomarkers
Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
Inna Markovna Chen, Victoria M. Raymond, Jennifer A. Geis, Eric Andrew Collisson, Benny Vittrup Jensen, Kirstine Lintrup Hermann, Mark G. Erlander, Margaret A. Tempero, Julia Sidenius Johansen · 2017 · Oncotarget
Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma
Li Zhang, Cuiping Wang, Shuangni Yu, Congwei Jia, Jie Yan, Zhaohui Lu, Jie Chen · 2018 · Technology in Cancer Research & Treatment
Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914–2016
Ruth A. Kleinerman, Margaret Anne Tucker, Byron S. Sigel, David H. Abramson, Johanna M. Seddon, Lindsay McOmber Morton · 2018 · JNCI Journal of the National Cancer Institute
Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review
Ritu Singh, Johanna Goldberg, Anna M. Varghese, Kenneth H. Yu, Wungki Park, Eileen Mary O'Reilly · 2019 · Cancer Treatment Reviews
Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
Emily Nicole Arner, Wenting Du, Rolf A. Brekken · 2019 · Frontiers in Oncology
Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
María Laura Gutiérrez, Luis Muñoz‐Bellvís, Alberto Órfão · 2021 · Cancers
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
Saiki, Yuriko, Jiang, Can, Ohmuraya, Masaki, Furukawa, Toru · 2021 · Cancers
Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance
Kendelle Joan Murphy, Cecilia R. Chambers, David Herrmann, Paul Timpson, Brooke Pereira · 2021 · Cancers
The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand–dependent Cancer Models
Caroline Phillips, Inder Bhamra, Catherine Eagle, Eimear Flanagan, Richard E Armer, Clifford D. Jones, Matilda J. Bingham, Peter J. Calcraft, Alicia Edmenson Cook, Ben Thompson et al. · 2022 · Cancer Research Communications
PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells by Down-regulating MMP9 Expression through the ERK/p65 Pathway
Yejiao Ruan, Guangrong Lu, Yaojun Yu, Yue Luo, Hao Wu, Yating Shen, Zejun Gao, Yao Shen, Zhenzhai Cai, Liyi Li · 2023 · Current Molecular Pharmacology
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study
Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Kaur Chela, Ebubekir S. Daglilar · 2024 · Cancers
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data
Nathalia Luisa Carlos Ferreira, Ajinkya Kulkarni, David Agorku, Teona Midelashvili, Olaf Hardt, Tobias Jörg Legler, Philipp Ströbel, Lena‐Christin Conradi, Frauke Alves, Fernanda Ramos‐Gomes et al. · 2024 · Cellular Oncology
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial
Jennifer Jane Knox, Gun Ho Jang, Robert C. Grant, Amy Xin Wei Zhang, Lucy X Ma, Elena C. Elimova, Raymond Jang, Malcolm J. Moore, James Joseph Biagi, Mustapha Ali Tehfe et al. · 2025 · Nature Communications
Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
Stephen J. Murphy, Steven N. Hart, Geoffrey C. Halling, Sarah H. Johnson, James B. Smadbeck, Travis Drucker, Joema Felipe Lima, Fariborz Rakhshan Rohakhtar, Faye R. Harris, Farhad Kosari et al. · 2015 · Cancer Research
RTK-RAS pathway mutation is enriched in myeloid sarcoma
Mihong Choi, Yoon Kyung Jeon, Choong-Hyun Sun, Hongseok Yun, Junshik Hong, Dong‐Yeop Shin, Inho Kim, Sung‐Soo Yoon, Youngil Koh · 2018 · Blood Cancer Journal
RBM10–TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break‐apart fluorescence in‐situ hybridisation: study of 10 cases and a literature review
Ikuma Kato, Mitsuko Furuya, Masaya Baba, Yoichi Kameda, Masanori Yasuda, Koshiro Nishimoto, Masafumi Oyama, Toshinari Yamasaki, Osamu Ogawa, Hitoshi Niino et al. · 2019 · Histopathology
The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma
Ho-June Lee, Trang Pham, Matthew T. Chang, Dwight Barnes, Allen G. Cai, Rajkumar Noubade, Klára Tótpál, Xu Chen, Christopher Tran, Thijs J. Hagenbeek et al. · 2020 · Cancer Research
MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Bastian Krenz, Anneli Gebhardt-Wolf, Carsten Patrick Ade, Abdallah Gaballa, Florian Roehrig, Emilia Vendelova, Apoorva Baluapuri, Ursula Eilers, Peter Gallant, Luana D’Artista et al. · 2021 · Cancer Research
ARID1A mutations in cancer development: mechanism and therapy
Xuewei Zhang, Yixuan Zhang, Jinyi Zhao, Yinjie Wu, Na Zhang, Wenjing Shen · 2023 · Carcinogenesis
Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility
Daisy J. A. Oketch, Matteo Giulietti, Francesco Piva · 2023 · International Journal of Molecular Sciences
Novel Regulation of Wnt Signaling at the Proximal Membrane Level
Xiaomo Jiang, Feng Cong · 2016 · Trends in Biochemical Sciences
Emerging themes of regulation at the Golgi
Stefanie L. Makowski, Thuy Thi Thu Tran, Seth J. Field · 2017 · Current Opinion in Cell Biology
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators
Brajesh Pratap Kaistha, Anja Krattenmacher, Johannes Fredebohm, Harald Schmidt, Diana Behrens, Miriam Widder, Thilo Hackert, Oliver Strobel, Jörg D. Hoheisel, Thomas Mathias Gress et al. · 2017 · Oncotarget
Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
Rie Iida‐Norita, Minaho Kawamura, Yasuhiro Suzuki, Shin Hamada, Atsushi Masamune, Toru Furukawa, Yasufumi Sato · 2019 · Cancer Science
The SUMO pathway in pancreatic cancer: insights and inhibition
Christian Schneeweis, Zonera Hassan, Markus Schick, Ulrich Bernd Keller, Günter Schneider · 2020 · British Journal of Cancer
Histone methylation in pancreatic cancer and its clinical implications
Xingyu Liu, Chuan-Hao Guo, Zhi-Yuan Xi, Xin-Qi Xu, Qing-Yang Zhao, Lisha Li, Ying Wang · 2021 · World Journal of Gastroenterology
KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review
Lei Zhou, Yoshifumi Baba, Yuki Kitano, Keisuke Miyake, Xiaobo Zhang, Kensuke Yamamura, Keisuke Kosumi, Takayoshi Kaida, Kota Arima, Katsunobu Taki et al. · 2016 · Medical Oncology
Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition
Dustin James Flanagan, Simon A. Woodcock, Caroline Phillips, Catherine Eagle, Owen James Sansom · 2022 · Pharmacology & Therapeutics
β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
Tzu‐Lei Kuo, Kuang‐Hung Cheng, Yan‐Shen Shan, Li‐Tzong Chen, Wen-Chun Hung · 2018 · Theranostics
Immunotherapy in pancreatic cancer: New hope or mission impossible?
Jiahong Jiang, Huaixiang Zhou, Chao Ni, Xiaoge Hu, Yiping Mou, Dongsheng Huang, Liu Yang · 2019 · Cancer Letters
Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation
Rongqin Ren, Somashekar Gopala Krishna, Wei Chen, Wendy L. Frankel, Rulong Z. Shen, Weiqiang Zhao, Matthew R. Avenarius, Jason P. Garee, Sean Caruthers, Dan M. Jones · 2020 · Modern Pathology
FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer
Norihiko Sasaki, Fujiya Gomi, Hisashi Yoshimura, Masami Yamamoto, Yoko Matsuda, Masaki Michishita, Hitoshi Hatakeyama, Yoichi Kawano, Masashi Toyoda, Murray Korc et al. · 2020 · Cancers
Recent advances in precision medicine for pancreatic ductal adenocarcinoma
Hiromitsu Hayashi, Takaaki Higashi, Tatsunori Miyata, Yo‐ichi Yamashita, Hideo Baba · 2021 · Annals of Gastroenterological Surgery
Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma
Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Jong Kyun Lee, Ji Hye Min, Seung Hyup Hyun · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
<i>KRAS</i> Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas
Diehl, Adam C, Hannan, Lindsay M, Zhen, David B, Coveler, Andrew L, King, Gentry, Cohen, Stacey A, Harris, William P, Shankaran, Veena, Wong, Kit M, Green, Steven et al. · 2022 · The Oncologist
SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment
Dalin Zhang, Aaron Raymond Lindstrom, Edward Jae-Hoon Kim, Chang‐Il Hwang, Madison Lee Hall, Tzu‐yin Lin, Yuanpei Li · 2022 · Frontiers in Oncology
Identification by FFPE RNA‐Seq of a new recurrent inversion leading to RBM10‐TFE3 fusion in renal cell carcinoma with subtle TFE3 break‐apart FISH pattern
Pierre‐Alexandre Just, Franck Letourneur, Christelle Pouliquen, Florence Dome, Anne Audebourg, P Biquet, Michel Vidaud, Benoît Terris, Mathilde Sibony, Éric Pasmant · 2016 · Genes Chromosomes and Cancer
Activated kinase screening identifies the IKBKE oncogene as a positive regulator of autophagy
Margherita Leonardi, Eluisa Perna, Serena Tronnolone, David Colecchia, Mario Chiariello · 2018 · Autophagy
Coordinately Targeting Cell-Cycle Checkpoint Functions in Integrated Models of Pancreatic Cancer
Sejin Chung, Paris J. Vail, Agnieszka Katarzyna Witkiewicz, Erik S. Knudsen · 2018 · Clinical Cancer Research
Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition
Ryne C. Ramaker, Andrew A. Hardigan, Emily R. Gordon, Carter Wright, R Myers, Sara J. Cooper · 2021 · BMC Cancer
The INO80 chromatin remodeler sustains metabolic stability by promoting TOR signaling and regulating histone acetylation
Sean L. Beckwith, Erin K. Schwartz, Pablo E. García-Nieto, Devin A. King, Graeme J. Gowans, Ka Man Wong, Wei Yao, Tessa L. Eckley, Alexander P. Paraschuk, Egan L. Peltan et al. · 2018 · PLoS Genetics
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Nebojša Skorupan, Mayrel Palestino Domínguez, Samuel L. Ricci, Christine Alewine · 2022 · Cancers
Comprehensive review on endoscopic ultrasound-guided tissue acquisition techniques for solid pancreatic tumor
Sakue Masuda, Kazuya Koizumi, Kento Shionoya, Ryuhei Jinushi, Makomo Makazu, Takashi Nishino, Karen A. Kimura, Chihiro Sumida, Jun Kubota, Chikamasa Ichita et al. · 2023 · World Journal of Gastroenterology
The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes
Thomas Paul Slavin, Susan L. Neuhausen, Bita Nehoray, Mariana Niell‐Swiller, Ilana B. Solomon, Christina Rybak, Kathleen Reilly Blazer, Aaron W. Adamson, Kai Yang, Sharon R. Sand et al. · 2017 · Familial Cancer
The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma
Motoyuki Tsuda, Akihisa Fukuda, Munenori Kawai, Osamu Araki, Hiroshi Seno · 2020 · Cancer Science
Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Dutta Gupta, Akash Chaurasiya · 2021 · International Immunopharmacology
Circulating tumor DNA as a predictive marker for occult metastases in pancreatic cancer patients with radiographically non‐metastatic disease
Tatsuo Hata, Masamichi Mizuma, Masahiro Iseki, Tatsuyuki Takadate, Masaharu Ishida, Kei Nakagawa, Hiroki Hayashi, Takanori Morikawa, Fuyuhiko Motoi, Michiaki Unno · 2021 · Journal of Hepato-Biliary-Pancreatic Sciences
Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype
Felix Orben, Katharina Lankes, Christian Schneeweis, Zonera Hassan, Hannah Jakubowsky, Lukas Krauß, Fabio Boniolo, Carolin Schneider, Arlett Schäfer, Janine Murr et al. · 2022 · JCI Insight
SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer
Ruizhe He, Juanjuan Shi, Dapeng Xu, Jian Yang, Yang Shen, Yongsheng Jiang, Ling‐Ye Tao, Minwei Yang, Xueliang Fu, Jian‐Yu Yang et al. · 2022 · Cancer Letters
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
Konstantinos Venetis, Chiara Frascarelli, Luca Boscolo Bielo, Giulia Cursano, Riccardo Adorisio, Mariia D. Ivanova, Eltjona Mane, Virginia Peruzzo, Alberto Concardi, Mariachiara Negrelli et al. · 2025 · European Journal of Cancer
The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling
Anke Bill, Larry Alex Gaither · 2017 · Advances in experimental medicine and biology
Functional role of RBM10 in lung adenocarcinoma proliferation
Xiuna Sun, Mengqi Jia, Wei Sun, Feng Lu, Chundong Gu, Taihua Wu · 2018 · International Journal of Oncology
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
Anna Maxi Wandmacher, Anne Letsch, Susanne Sebens · 2021 · Cancers
RNA-binding proteins of COSMIC importance in cancer
Peter S. Choi, Andrei Thomas‐Tikhonenko · 2021 · Journal of Clinical Investigation
Precision medicine for KRAS wild-type pancreatic adenocarcinomas
Imen Ben-Ammar, Adrien Rousseau, Rémy Nicolle, Anthony Tarabay, Valérie Boige, Marine Valéry, Thomas Pudlarz, David Malka, Maximiliano Gelli, Elena Fernandez-De-Sevilla et al. · 2023 · European Journal of Cancer
Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges
Jie Yan, Shuangni Yu, Congwei Jia, Min Li, Jie Chen · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics
Walaa E. Kattan, John F. Hancock · 2020 · Biochemical Journal
Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin
M. Reichert, Karin Blume, A. Kleger, D. Hartmann, G. von Figura · 2015 · Stem Cells International
Identifying MMP14 and COL12A1 as a potential combination of prognostic biomarkers in pancreatic ductal adenocarcinoma using integrated bioinformatics analysis
Jingyi Ding, Yanxi Liu, Yu Lai · 2020 · PeerJ
Critical role of KRAS mutation in pancreatic ductal adenocarcinoma
Zhiyao Fan, Kun Fan, Chao Yan, Qiuyi Huang, Yitao Gong, He Cheng, Kaizhou Jin, Chen Liu, Quanxing Ni, Xianjun Yu et al. · 2018 · Translational Cancer Research
Multi-omic molecular comparison of primary versus metastatic pancreatic tumours
Gagandeep Singh Brar, Edik Matthew Blais, R Joseph Bender, Jonathan Robert Brody, Davendra P. S. Sohal, Subha Madhavan, Vincent J. Picozzi, Andrew Eugene Hendifar, Vincent M. Chung, David Halverson et al. · 2019 · British Journal of Cancer
K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis
Tao Li, Yuanting Zheng, Hong Sun, Rongyuan Zhuang, Jing Liu, Tianshu Liu, Weimin Cai · 2016 · Medical Oncology
Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications
Brittany Silverman, Jiaqi Shi · 2016 · International Journal of Molecular Sciences
Single-Cell mRNA Sequencing in Cancer Research: Integrating the Genomic Fingerprint
Sören Müller, Aaron A. Diaz · 2017 · Frontiers in Genetics
K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma
Yoko Sekita‐Hatakeyama, Takeshi Nishikawa, Mao Takeuchi, Kouhei Morita, Maiko Takeda, Kinta Hatakeyama, Tokiko Nakai, Tomoko Uchiyama, Hiroe Itami, Tomomi Fujii et al. · 2018 · PLoS ONE
Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer
Jing Du, Yuanqiao He, Weiquan Wu, Peng Li, Youwei Chen, Zhiming Hu, Yong Han · 2019 · Journal of Pharmacy and Pharmacology
Novel therapeutic approaches for pancreatic cancer by combined targeting of RAF→MEK→ERK signaling and autophagy survival response
Faustino Mollinedo, Consuelo Gajate · 2019 · Annals of Translational Medicine
ATM Serine/Threonine Kinase and its Role in Pancreatic Risk
Neha Nanda, Nicholas Jason Roberts · 2020 · Genes
Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies
Andrew Eugene Hendifar, Edik Matthew Blais, Brian Matthew Wolpin, Vivek Subbiah, Eric Andrew Collisson, Isha Singh, Timothy Lewis Cannon, Kenna R Mills Shaw, Emanuel F. Petricoin, Samuel Jacob Klempner et al. · 2021 · JCO Precision Oncology
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J. Nathaniel Diehl, Jennifer E. Klomp, Kayla R. Snare, Priya S. Hibshman, Devon R. Blake, Zane D. Kaiser, Thomas S.K. Gilbert, Elisa Baldelli, Mariaelena Pierobon, Bjoern Papke et al. · 2021 · Journal of Biological Chemistry
The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
Marie-Lucie Racu, Laetitia Lebrun, Andréa Alex Schiavo, Claude Van Campenhout, Sarah De Clercq, Lara Absil, Esmeralda Minguijón, Calliope Maris, Christine Decaestecker, Isabelle J. Salmon et al. · 2022 · Cancers
Spatial Transcriptomics Reveals Cancer and Stromal Cell Heterogeneity Between Center and Invasive Front of Pancreatic Cancer
Tine Norman Alver, Helga Bergholtz, Maia Blomhoff Holm, Linda Trobe Dorg, Martina Landschoof Skrede, Elin Hegland Kure, Caroline Sophie Verbeke · 2025 · Modern Pathology
Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies
Trang H. Au, Kai Wang, David Dean Stenehjem, Ignacio Garrido‐Laguna · 2017 · Journal of Gastrointestinal Oncology
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer
David Jérémie Birnbaum, François Bertucci, Pascal Finetti, Daniel Birnbaum, Émilie Mamessier · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
Koji Miyabayashi, Hayato Nakagawa, Kazuhiko Koike · 2021 · Frontiers in Oncology
Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth
Yihui Sun, Jiaming Xie, Shang Cai, Qian Wang, Zhenyu Feng, Yecheng Li, Jingjing Lu, Wei Chen, Zhenyu Ye · 2021 · Cell Death and Disease
Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway
Yuichi Fukunaga, Akihisa Fukuda, Mayuki Omatsu, Mio Namikawa, Makoto Sono, Tomonori Masuda, Osamu Araki, Munemasa Nagao, Takaaki Yoshikawa, Satoshi Ogawa et al. · 2022 · Gastroenterology
An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation-Negative Pancreatic Ductal Adenocarcinoma
Yoko Shimada, Takashi Kohno, Hideki Ueno, Yoshinori Ino, Hideyuki Hayashi, Takashi Nakaoku, Yasunari Sakamoto, Shunsuke Kondo, Chigusa Morizane, Kazuaki Shimada et al. · 2017 · The Oncologist
Multi-Omics Analysis Based on Integrated Genomics, Epigenomics and Transcriptomics in Pancreatic Cancer
Lingming Kong, Peng Liu, Mingjun Zheng, Busheng Xue, Keke Liang, Xiaodong Tan · 2020 · Epigenomics
Characterization of pancreatic cancer with ultra-low tumor mutational burden
Taisuke Imamura, Ryo Ashida, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Keiichi Hatakeyama, Takeshi Nagashima et al. · 2023 · Scientific Reports
Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer
Yohei Watanabe, Motonobu Saito, Katsuharu Saito, Yoshiko Matsumoto, Yasuyuki Kanke, Hisashi Onozawa, Suguru Hayase, Wataru Sakamoto, Teruhide Ishigame, Tomoyuki Momma et al. · 2017 · Oncology Letters
Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
Hao Chen, Gang Yang, Jianchun Xiao, Lianfang Zheng, Lei You, Taiping Zhang · 2020 · Cancer Letters
A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
Benjamin Adam Weinberg, Hongkun Wang, Agnieszka Katarzyna Witkiewicz, John Lindsay Marshall, Aiwu Ruth He, Paris J. Vail, Erik S. Knudsen, Michael Jon Pishvaian · 2020 · Journal of Pancreatic Cancer
Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis
Alireza Tabibzadeh, Fahimeh Safarnezhad Tameshkel, Yousef Moradi, Saber Soltani, Maziar Moradi‐Lakeh, Gholam Hossein Ashrafi, Nima Motamed, Farhad Zamani, Seyed Abbas Motevalian, Mahshid Panahi et al. · 2020 · Scientific Reports